Multitarget antibacterial drugs: An effective strategy to combat bacterial resistance

J Feng, Y Zheng, W Ma, A Ihsan, H Hao… - Pharmacology & …, 2023 - Elsevier
The rise of antibiotic resistance and the decrease in the discovery of new antibiotics have
caused a global health crisis. Of particular concern is the fact that despite efforts to develop …

Dual inhibitors of HDAC and other epigenetic regulators: A novel strategy for cancer treatment

E Shirbhate, V Singh, V Jahoriya, A Mishra… - European journal of …, 2024 - Elsevier
A significant advancement in the field of epigenetic drug discovery has been evidenced in
recent years. Epigenetic alterations are hereditary, nevertheless reversible variations to …

Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) …

SA Amin, S Khatun, S Gayen, S Das, T Jha - European Journal of Medicinal …, 2023 - Elsevier
Abstract Histone deacetylase 8 (HDAC8) aberrantly deacetylates histone and non-histone
proteins. These include structural maintenance of chromosome 3 (SMC3) cohesin protein …

The histone deacetylase family: structural features and application of combined computational methods

A Curcio, R Rocca, S Alcaro, A Artese - Pharmaceuticals, 2024 - mdpi.com
Histone deacetylases (HDACs) are crucial in gene transcription, removing acetyl groups
from histones. They also influence the deacetylation of non-histone proteins, contributing to …

Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer's diseases therapy

OM Soltan, KS Abdelrahman, AKA Bass, K Takizawa… - Bioorganic …, 2024 - Elsevier
Alzheimer disease (AD) is the most prevalent form of dementia that develops spontaneously
in the elderly. It's worth mentioning that as people age, the epigenetic profile of the central …

Asclepiadoideae subfamily (Apocynaceae): ethnopharmacology, biological activities and chemophenetics based on pregnane glycosides

TA de Souza, FSV Lins, J da Silva Lins, AF Alves… - Phytochemistry …, 2024 - Springer
Apocynaceae, one of the largest plant families with over 5.100 widely distributed species,
serves as a significant model for evolutionary and biochemical studies. Within this family …

Discovery of Highly Potent and Orally Bioavailable Histone Deacetylase 3 Inhibitors as Immunomodulators and Enhancers of DNA-Damage Response in Cancer …

S Li, Z Hu, W Pan, H Wu, W Peng, Y Wu… - Journal of Medicinal …, 2025 - ACS Publications
Histone deacetylase 3 (HDAC3) is a well-established target for cancer therapy. Herein, we
developed LSQ-28 as a novel HDAC3 inhibitor, which exhibited high HDAC3 inhibitory …

Improving the Thrombocytopenia Adverse Reaction of Belinostat Using Human Serum Albumin Nanoparticles

JY Liu, CH Yen, YF Lin, YH Feng… - International Journal of …, 2024 - Taylor & Francis
Background Belinostat, a histone deacetylase inhibitor used for hematological cancer
treatments, however, it caused thrombocytopenia, poor solubility, and rapid clearance. To …

Deacetylation of histones and non-histone proteins in inflammatory diseases and cancer therapeutic potential of histone deacetylase inhibitors

E Man, S Evran - Current Genomics, 2023 - benthamdirect.com
Epigenetic changes play an important role in the pathophysiology of autoimmune diseases
such as allergic asthma, multiple sclerosis, lung diseases, diabetes, cystic fibrosis …

Synergistic strategies: histone deacetylase inhibitors and platinum-based drugs in cancer therapy

E Shirbhate, V Singh, R Kore, B Koch… - Expert Review of …, 2025 - Taylor & Francis
Introduction The synergistic combination of histone deacetylase inhibitors and platinum-
based medicines represents a promising therapeutic strategy to efficacy and overcome drug …